Please login (Members) to view content or
(Nonmembers) this article.
Average: 5 (1 vote)
Online Exclusive Article

Medullary Thyroid Cancer: Overview and Case Study of a Rare Cancer

Lynn Jakobs
CJON 2018, 22(2), E37-E43 DOI: 10.1188/18.CJON.E37-E43

Background: Medullary thyroid cancer (MTC) is a rare cancer that has historically been managed by endocrinologists. In 2011, the first of several multi-targeted tyrosine kinase inhibitors was approved as treatment for MTC. These drugs have changed the management of MTC to teams that include oncologists and oncology nurses.

Objectives: This article illustrates MTC diagnostics, surveillance, management of adverse drug reactions, and disease progression through a case study.

Methods: An overview of MTC is offered, followed by an in-depth case study that examines MTC from the patient’s perspective.

Findings: Oncology nurses can influence patient outcomes through the provision of patient education, support, and management of disease and treatment complications.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or